ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,049,000 | +54.1% | 38,326 | +18.9% | 0.01% | +50.0% |
| Q3 2020 | $1,330,000 | -17.1% | 32,226 | -2.6% | 0.00% | -33.3% |
| Q2 2020 | $1,604,000 | +27.3% | 33,083 | +10.9% | 0.01% | 0.0% |
| Q1 2020 | $1,260,000 | +5.4% | 29,821 | +6.7% | 0.01% | +50.0% |
| Q4 2019 | $1,196,000 | +35.3% | 27,953 | +13.8% | 0.00% | +33.3% |
| Q3 2019 | $884,000 | +54.5% | 24,568 | +14.9% | 0.00% | +50.0% |
| Q2 2019 | $572,000 | +23.5% | 21,384 | +23.9% | 0.00% | 0.0% |
| Q1 2019 | $463,000 | +80.2% | 17,257 | +8.4% | 0.00% | +100.0% |
| Q4 2018 | $257,000 | -20.9% | 15,918 | +1.5% | 0.00% | 0.0% |
| Q3 2018 | $325,000 | +28.5% | 15,679 | -5.5% | 0.00% | 0.0% |
| Q2 2018 | $253,000 | -35.9% | 16,586 | -5.7% | 0.00% | -50.0% |
| Q1 2018 | $395,000 | -28.1% | 17,593 | -3.5% | 0.00% | -33.3% |
| Q4 2017 | $549,000 | -19.1% | 18,226 | +1.1% | 0.00% | -25.0% |
| Q3 2017 | $679,000 | +37.2% | 18,031 | +1.6% | 0.00% | +33.3% |
| Q2 2017 | $495,000 | -31.2% | 17,752 | -15.3% | 0.00% | -40.0% |
| Q1 2017 | $720,000 | +20.6% | 20,951 | +1.3% | 0.01% | 0.0% |
| Q4 2016 | $597,000 | +1.2% | 20,688 | +11.5% | 0.01% | +25.0% |
| Q3 2016 | $590,000 | +2.1% | 18,557 | +4.3% | 0.00% | -20.0% |
| Q2 2016 | $578,000 | +9.1% | 17,797 | -6.2% | 0.01% | 0.0% |
| Q1 2016 | $530,000 | +1.5% | 18,964 | +29.6% | 0.01% | 0.0% |
| Q4 2015 | $522,000 | +14.0% | 14,629 | +5.5% | 0.01% | 0.0% |
| Q3 2015 | $458,000 | -22.8% | 13,860 | -2.1% | 0.01% | -16.7% |
| Q2 2015 | $593,000 | +105.2% | 14,156 | +59.7% | 0.01% | +100.0% |
| Q1 2015 | $289,000 | +3.6% | 8,866 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $279,000 | +36.1% | 8,773 | +4.2% | 0.00% | 0.0% |
| Q1 2014 | $205,000 | -6.4% | 8,421 | +5.4% | 0.00% | -25.0% |
| Q3 2013 | $219,000 | – | 7,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |